BAQUELA Trademark

Trademark Overview

On Friday, February 24, 2012, a trademark application was filed for BAQUELA with the United States Patent and Trademark Office. The USPTO has given the BAQUELA trademark a serial number of 85551800. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 31, 2021. This trademark is owned by Glaxo Group Limited. The BAQUELA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
baquela

General Information

Serial Number85551800
Word MarkBAQUELA
Filing DateFriday, February 24, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 31, 2021
Registration Number4762635
Registration DateTuesday, June 30, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "BAQUELA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 31, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, December 31, 2021CANCELLED SEC. 8 (6-YR)
Tuesday, June 30, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 30, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, April 14, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2015PUBLISHED FOR OPPOSITION
Wednesday, March 25, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 10, 2015NOTICE OF ALLOWANCE CANCELLED
Monday, March 2, 2015ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Monday, February 23, 2015PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, February 26, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 25, 2015EXTENSION 5 GRANTED
Friday, February 13, 2015EXTENSION 5 FILED
Monday, February 23, 2015ASSIGNED TO PETITION STAFF
Friday, February 13, 2015TEAS EXTENSION RECEIVED
Friday, February 13, 2015TEAS PETITION TO AMEND BASIS RECEIVED
Friday, September 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 4, 2014EXTENSION 4 GRANTED
Wednesday, September 3, 2014EXTENSION 4 FILED
Wednesday, September 3, 2014TEAS EXTENSION RECEIVED
Saturday, March 22, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 21, 2014EXTENSION 3 GRANTED
Tuesday, March 4, 2014EXTENSION 3 FILED
Tuesday, March 4, 2014TEAS EXTENSION RECEIVED
Wednesday, October 16, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 15, 2013EXTENSION 2 GRANTED
Wednesday, September 4, 2013EXTENSION 2 FILED
Friday, October 11, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 4, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, March 2, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 28, 2013EXTENSION 1 GRANTED
Thursday, February 28, 2013EXTENSION 1 FILED
Thursday, February 28, 2013TEAS EXTENSION RECEIVED
Tuesday, September 4, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 10, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 10, 2012PUBLISHED FOR OPPOSITION
Wednesday, June 20, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 5, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 5, 2012ASSIGNED TO EXAMINER
Friday, March 2, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 28, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

baquela pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological